<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0147621</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3548</journal-id>
<journal-id journal-id-type="nlm-ta">Environ Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Environ. Res.</journal-id>
<journal-title-group>
<journal-title>Environmental research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0013-9351</issn>
<issn pub-type="epub">1096-0953</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30665119</article-id>
<article-id pub-id-type="pmc">6382542</article-id>
<article-id pub-id-type="doi">10.1016/j.envres.2018.12.061</article-id>
<article-id pub-id-type="manuscript">NIHMS1519117</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Polychlorinated biphenyls influence on autism spectrum disorder risk in the MARBLES cohort</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Granillo</surname>
<given-names>Lauren</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sethi</surname>
<given-names>Sunjay</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Keil</surname>
<given-names>Kimberly P.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Yanping</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ozonoff</surname>
<given-names>Sally</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Iosif</surname>
<given-names>Ana-Maria</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Puschner</surname>
<given-names>Birgit</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schmidt</surname>
<given-names>Rebecca J.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Graduate Group in Epidemiology, School of Veterinary Medicine, University of California, Davis, Davis, CA, USA</aff>
<aff id="A2"><label>2</label>Department of Molecular Biosciences, School of Veterinary Medicine, University of California Davis, Davis, CA, USA</aff>
<aff id="A3"><label>3</label>MIND Institute, School of Medicine, University of California, Davis, Sacramento, CA, USA</aff>
<aff id="A4"><label>4</label>Department of Psychiatry and Behavioral Sciences, School of Medicine, University of California Davis, Sacramento, CA, USA</aff>
<aff id="A5"><label>5</label>Department of Public Health Sciences, School of Medicine, University of California, Davis, Davis, CA, USA</aff>
<author-notes>
<corresp id="CR1"><label>*</label><bold>Corresponding Author:</bold> Lauren Granillo, 123 Med Sci 1C One Shields Ave, University of California, Davis, Davis, CA 95616, Telephone: 951-532-1752, FAX: (530) 752-3239, <email>lpgranillo@ucdavis.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>23</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>25</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>4</month>
<year>2020</year>
</pub-date>
<volume>171</volume>
<fpage>177</fpage>
<lpage>184</lpage>
<!--elocation-id from pubmed: 10.1016/j.envres.2018.12.061-->
<abstract id="ABS1">
<sec id="S1">
<title>Background:</title>
<p id="P1">Autism spectrum disorder (ASD) is suspected to have environmental and genetic contributions. Polychlorinated biphenyls (PCBs) are environmental risk factors of interest due to their potential as neurodevelopmental toxicants and environmental persistence despite a US production ban in the 1970s.</p>
</sec>
<sec id="S2">
<title>Methods:</title>
<p id="P2">Participants were mother-child pairs from MARBLES, a high-risk pregnancy cohort that enrolls families who have one child diagnosed with ASD and are planning to have another child. PCB concentrations were measured in maternal blood at each trimester of pregnancy using gas chromatography coupled with triple quadruple mass spectrometry. Concentrations were summed into total PCB and two categories based on function/mechanisms of action: dioxin-like (DL), and ryanodine receptor (RyR)-activating PCBs. Multinomial logistic regression assessed risk of clinical diagnosis of ASD and non-typical development (Non-TD) compared to typically developing (TD) in the children at 3 years old.</p>
</sec>
<sec id="S3">
<title>Results:</title>
<p id="P3">A total of 104 mother-child pairs were included. There were no significant associations for total PCB; however, there were borderline significant associations between DL-PCBs and decreased risk for Non-TD diagnosis (adjusted OR: 0.41 (95% CI 0.15 to 1.14)) and between RyR-activating PCBs and increased risk for ASD diagnosis (adjusted OR: 2.63 (95% CI 0.87 to 7.97)).</p>
</sec>
<sec id="S4">
<title>Conclusion:</title>
<p id="P4">This study does not provide strong supporting evidence that PCBs are risk factors for ASD or Non-TD. However, these analyses suggest the need to explore more deeply into subsets of PCBs as risk factors based on their function and structure in larger cohort studies where non-monotonic dose-response patterns can be better evaluated.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Polychlorinated Biphenyls</kwd>
<kwd>Autism</kwd>
<kwd>Pregnancy</kwd>
<kwd>Ryanodine Receptor</kwd>
<kwd>Prospective Study</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>